D118 Unit 6 Study Guide
Student Name
Western Governors University
D118 Adult Primary Care for the Advanced Practice Nurse
Prof. Name
Date
D118 Unit 6 Study Guide
Discuss the Treatment for a Patient With Alzheimer’s Disease Who Is Experiencing Depression
Depression frequently coexists with Alzheimer’s disease and represents one of the most prevalent neuropsychiatric complications in this population. Its presence is associated with accelerated cognitive deterioration, diminished functional independence, increased behavioral disturbances, and heightened caregiver burden. Effective management therefore requires an integrated approach that balances symptom relief with patient safety, particularly given age-related pharmacokinetic changes and polypharmacy risks.
What is the preferred medication for treating depression in Alzheimer’s disease?
Selective serotonin reuptake inhibitors (SSRIs) are widely regarded as the first-line pharmacologic option for managing depression in individuals with Alzheimer’s disease. These medications are preferred because they demonstrate favorable tolerability, limited anticholinergic effects, and reduced drug–drug interaction potential when compared with older antidepressant classes. Agents such as sertraline and citalopram have demonstrated efficacy in improving mood symptoms, reducing anxiety, and stabilizing emotional lability in this population. Careful dose titration and close monitoring are essential to minimize adverse effects such as hyponatremia or QT prolongation, particularly in frail older adults.
What nonpharmacologic strategies complement medication treatment?
Nonpharmacologic interventions play a critical supportive role and should be implemented alongside pharmacotherapy. These strategies include maintaining structured daily routines, engaging patients in cognitively stimulating and socially meaningful activities, and providing caregiver education to enhance communication and behavioral management. Psychosocial interventions, environmental modifications, and emotional reassurance can significantly reduce depressive symptoms. When depression proves refractory or severe, referral to geriatric psychiatry or neuropsychiatry is warranted for advanced management.
What Is the Treatment for Guillain-Barré Syndrome?
Guillain-Barré syndrome (GBS) is an acute, immune-mediated demyelinating neuropathy characterized by rapidly progressive, symmetrical muscle weakness that may lead to respiratory compromise. Early recognition and prompt treatment are critical to reducing morbidity and mortality.
The primary disease-modifying treatments for GBS include intravenous immunoglobulin (IVIG) and plasma exchange (plasmapheresis). IVIG is often preferred due to ease of administration and comparable efficacy, functioning by neutralizing pathogenic antibodies and modulating immune responses. Plasma exchange serves as an effective alternative, particularly in patients who cannot tolerate IVIG or when IVIG is contraindicated.
What supportive care is essential in GBS?
Supportive care is a cornerstone of GBS management and includes vigilant respiratory monitoring, especially of vital capacity, to detect impending respiratory failure. Preventive measures against complications such as deep vein thrombosis, autonomic instability, and pressure injuries are essential. Early initiation of physical and occupational therapy supports neuromuscular recovery and reduces long-term disability.
What Is Ankylosing Spondylitis and How Does It Relate to Seronegative Spondyloarthropathies?
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disorder predominantly affecting the axial skeleton, including the sacroiliac joints and spine. It is classified within the broader category of seronegative spondyloarthropathies, a group of inflammatory conditions that share overlapping clinical, genetic, and radiographic features.
These disorders are characteristically negative for rheumatoid factor and demonstrate a strong association with the HLA-B27 genetic marker. Related conditions include reactive arthritis, psoriatic arthritis, enteropathic arthritis associated with inflammatory bowel disease, and undifferentiated spondyloarthritis. Early diagnosis and timely intervention are essential to prevent irreversible spinal fusion, postural deformity, and loss of mobility.
What Are the Common Laboratory Findings Associated With Paget Disease of Bone?
Paget disease of bone is a metabolic disorder characterized by disorganized bone remodeling, resulting in structurally weak and deformed bones. Laboratory evaluation is instrumental in diagnosis and disease monitoring.
Laboratory Findings in Paget Disease of Bone
| Laboratory Test | Typical Finding | Clinical Significance |
|---|---|---|
| Alkaline phosphatase (ALP) | Elevated | Reflects increased osteoblastic activity and bone turnover |
| Serum calcium | Usually normal | May rise during prolonged immobilization |
| Serum phosphorus | Normal | Helps differentiate from other metabolic bone diseases |
An elevated serum ALP level is the most common laboratory abnormality and serves as a useful marker of disease activity. Additional tests, such as bone-specific ALP and urinary hydroxyproline, may provide further insight into disease severity.
Discuss the Diagnosis, Treatment, and Referral for a Patient With Infectious Arthritis
Infectious arthritis is a medical emergency that can rapidly destroy joint structures if not promptly treated. Patients typically present with acute onset of joint pain, swelling, warmth, erythema, fever, and restricted range of motion, with the knee being the most frequently involved joint.
Diagnosis begins with a detailed clinical assessment and is confirmed through joint aspiration, which remains the diagnostic gold standard. Synovial fluid analysis includes Gram stain, culture, leukocyte count, and crystal examination. Imaging studies such as radiographs or magnetic resonance imaging may be used to evaluate joint damage or complications.
Management requires immediate initiation of empiric intravenous antibiotics, later tailored based on culture and sensitivity results. Effective joint drainage through repeated aspiration, arthroscopy, or surgical intervention is often necessary. Early referral to orthopedic surgery and infectious disease specialists is critical for optimal outcomes.
What Are the Common Manifestations of Osteoarthritis and What Is the Treatment Plan?
Osteoarthritis (OA) is a chronic degenerative joint disorder marked by progressive cartilage breakdown and secondary bone changes. Symptoms typically develop gradually and include joint pain that worsens with activity, stiffness after periods of rest, and reduced mobility.
Physical examination findings commonly include crepitus, joint enlargement, decreased range of motion, and occasional effusions. Weight-bearing joints such as the knees, hips, and spine are most frequently affected.
Management focuses on symptom control and functional preservation. Acetaminophen is recommended as initial pharmacologic therapy for mild pain, while nonsteroidal anti-inflammatory drugs are reserved for moderate symptoms. Intra-articular hyaluronic acid injections may provide benefit in selected patients. Nonpharmacologic strategies, including weight reduction, structured exercise, and physical therapy, remain foundational to treatment.
What Medications and Dosages Are Appropriate in Treating Osteoporosis?
The pharmacologic treatment of osteoporosis aims to reduce fracture risk by improving bone mineral density and skeletal strength. Oral bisphosphonates are the first-line agents and require strict adherence to administration guidelines to enhance absorption and minimize gastrointestinal side effects. These medications should be taken on an empty stomach with water, followed by remaining upright for at least 30 minutes; ibandronate requires a 60-minute interval.
Raloxifene, a selective estrogen receptor modulator, is approved for both prevention and treatment of postmenopausal osteoporosis at a standard dose of 60 mg once daily. Treatment selection should consider patient-specific fracture risk, comorbidities, and tolerability.
Differentiate the Types of Dementia
Dementia encompasses a group of neurocognitive disorders characterized by progressive impairment in memory, reasoning, and functional abilities. The most prevalent subtypes include Alzheimer’s disease, vascular dementia, and Lewy body dementia.
Comparison of Common Dementia Types
| Type of Dementia | Pathophysiology | Key Clinical Features |
|---|---|---|
| Alzheimer’s disease | Amyloid plaques and neurofibrillary tangles | Gradual memory decline, cortical atrophy |
| Vascular dementia | Cerebral ischemia and infarction | Stepwise decline, focal neurologic deficits |
| Lewy body dementia | Alpha-synuclein (Lewy body) deposition | Visual hallucinations, fluctuating cognition |
Discuss the Treatment for Gout
Gout is an inflammatory arthropathy caused by deposition of monosodium urate crystals within joints. Definitive diagnosis is achieved through synovial fluid analysis demonstrating negatively birefringent crystals.
Acute gout flares are treated with nonsteroidal anti-inflammatory drugs or systemic corticosteroids. Corticosteroids are particularly appropriate for patients with renal impairment, anticoagulant use, or gastrointestinal contraindications. Early initiation of therapy within the first 24 to 48 hours is essential for rapid symptom resolution.
What Are the Common Manifestations of Rheumatoid Arthritis and the Treatment Plan?
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic, symmetric inflammation of synovial joints. Patients commonly experience prolonged morning stiffness, joint swelling, fatigue, and unintentional weight loss.
The disease typically begins in the small joints of the hands and feet. Early and aggressive treatment with disease-modifying antirheumatic drugs (DMARDs), often supplemented with biologic agents, nonsteroidal anti-inflammatory drugs, and short-term glucocorticoids, is essential to control inflammation and prevent irreversible joint damage.
What Medication Is Appropriate for Dyskinesia in an Alzheimer’s Patient?
In patients with Alzheimer’s disease who develop tardive dyskinesia, anticholinergic medications such as benztropine should be avoided due to their potential to worsen cognitive impairment. Management involves discontinuation of the offending medication, consideration of switching to an atypical antipsychotic with a lower risk profile, and referral to psychiatric specialists for ongoing management when symptoms persist.
What Medications Are Considered for Insomnia in a Patient With Fibromyalgia?
Sleep disturbances are a hallmark feature of fibromyalgia and significantly contribute to symptom burden. Pharmacologic options such as trazodone and zolpidem may aid sleep initiation and maintenance; however, they do not substantially improve restorative slow-wave sleep. Consequently, nonpharmacologic strategies, including sleep hygiene education, cognitive behavioral therapy, and regular sleep–wake schedules, remain central to effective management.
Define Migraine and Describe Its Signs and Symptoms
Migraine is a chronic neurovascular headache disorder characterized by recurrent attacks of moderate to severe head pain. Migraine without aura, the most common subtype, presents as unilateral, throbbing pain lasting 4 to 72 hours and is frequently accompanied by nausea, photophobia, and phonophobia.
Migraine with aura is preceded by transient neurological symptoms such as visual disturbances, sensory changes, or speech impairment. Many individuals also experience prodromal symptoms, including fatigue, mood changes, and food cravings, hours to days before headache onset.
What Are the Common Manifestations of Meningitis, How Is It Diagnosed, and What Is the Treatment Plan?
Acute bacterial meningitis is a life-threatening condition that typically presents with fever, headache, and nuchal rigidity, though older adults may exhibit atypical manifestations such as confusion or altered mental status.
Diagnosis requires prompt blood cultures and lumbar puncture for cerebrospinal fluid analysis. Empiric antimicrobial therapy must be initiated immediately, often including vancomycin to address resistant organisms, and later adjusted based on microbiological results.
References
American College of Rheumatology. (2020). Guidelines for the management of rheumatoid arthritis. https://www.rheumatology.org
Harrison, T. R., & Fauci, A. S. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill Education.
National Institute on Aging. (2023). Alzheimer’s disease and related dementias. https://www.nia.nih.gov
UpToDate. (2024). Clinical manifestations and treatment of osteoarthritis. Wolters Kluwer.
World Health Organization. (2022). Neurological disorders: Public health challenges. https://www.who.int
Get WGU Free MSN Samples
D024
- D024 SEI Skill Sets Discussion – Self-Awareness & Management Insights
- D024 Phase 1 Video Reflection
- D024 CPE Schedule and SEI Reflection Report
- D024 FAQ: Submission and CPE Record Guidance
- D024 Phase 1 Reflection on Leadership and Growth Strategies
- D024 Joy in the Workplace: Force Field Analysis Summary
- D024 Professional Presence & Influence: CPE Record Template Task 1
D025
- D025 Phase 2 Reflection: Insights on Team Leadership and Advocacy
- D025: Phase 1 Reflection on Health Policy Advocacy Insights
- D025 Task 1: Clinical Practice Experience
- D025 Task 1 ISBAR Summary
- D025 Final Exam: Advocacy for Policy Change in Community Health
- D025 Task 2 Advocating for Policy Change to Improve Health Outcomes in the Community
D026
D027
- D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects
- D027 OA Final Exam Study Guide: Key Concepts and Conditions
- D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
- D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
- D027 – Comprehensive Study Guide for Health Disorders and Treatments
- D027 E-Portfolio: Advanced Pathopharmacological Foundations
- D027 Study Guide – Advanced Pathopharmacology Notes
D028
D029
- D029 Narrative Essay: Innovations in Nursing Informatics
- D029 CPE Phase 2
- D029 Emerging Tech Annotated Bibliography for Nursing Care
- D029 Annotated Bibliography
- D029 Population Health Data Paper
- D029 Task 1 E-Portfolio: Clinical Practice Experience Analysis
- D029 Task 1: Analyzing Population Health Data in Strafford Country
D030
D031